Aileen Hoehne

1.4k total citations · 1 hit paper
22 papers, 763 citations indexed

About

Aileen Hoehne is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Aileen Hoehne has authored 22 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Aileen Hoehne's work include Radiopharmaceutical Chemistry and Applications (7 papers), Peptidase Inhibition and Analysis (7 papers) and Medical Imaging Techniques and Applications (5 papers). Aileen Hoehne is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Peptidase Inhibition and Analysis (7 papers) and Medical Imaging Techniques and Applications (5 papers). Aileen Hoehne collaborates with scholars based in United States, Germany and United Kingdom. Aileen Hoehne's co-authors include Sanjiv S. Gambhir, Gayatri Gowrishankar, Mohammad Namavari, Frank Osterkamp, Dirk Zboralski, Robert E. Reeves, Michelle L. James, Christiane Smerling, Ulrich Reineke and Richard P. Baum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Experimental Medicine.

In The Last Decade

Aileen Hoehne

22 papers receiving 757 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

2021 210 citations Richard P. Baum, Christiane Schuchardt et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aileen Hoehne United States	15	305	235	205	160	146	22	763
Franz Josef Gildehaus Germany	20	328 1.1×	972 4.1×	247 1.2×	67 0.4×	99 0.7×	58	1.7k
Maria Hersom Denmark	9	326 1.1×	191 0.8×	267 1.3×	55 0.3×	71 0.5×	10	760
David M. Nanus United States	13	350 1.1×	135 0.6×	442 2.2×	58 0.4×	118 0.8×	27	902
Manuel Pérez‐Martínez Spain	13	294 1.0×	112 0.5×	494 2.4×	71 0.4×	144 1.0×	23	1.1k
Kongzhen Hu China	18	487 1.6×	322 1.4×	207 1.0×	238 1.5×	236 1.6×	64	918
Núria Colomé Spain	16	122 0.4×	116 0.5×	421 2.1×	57 0.4×	120 0.8×	25	768
Joan Josep Bech‐Serra Spain	17	368 1.2×	166 0.7×	712 3.5×	36 0.2×	202 1.4×	34	1.1k
Motokazu Ito Japan	19	200 0.7×	67 0.3×	461 2.2×	45 0.3×	200 1.4×	22	943
Roland T. Ullrich Germany	19	231 0.8×	490 2.1×	334 1.6×	38 0.2×	242 1.7×	38	1.1k
Sani H. Kizilbash United States	16	444 1.5×	168 0.7×	453 2.2×	34 0.2×	199 1.4×	76	1.4k

Countries citing papers authored by Aileen Hoehne

Since Specialization

Citations

This map shows the geographic impact of Aileen Hoehne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen Hoehne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen Hoehne more than expected).

Fields of papers citing papers by Aileen Hoehne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aileen Hoehne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen Hoehne. The network helps show where Aileen Hoehne may publish in the future.

Co-authorship network of co-authors of Aileen Hoehne

This figure shows the co-authorship network connecting the top 25 collaborators of Aileen Hoehne. A scholar is included among the top collaborators of Aileen Hoehne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen Hoehne. Aileen Hoehne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiedemann, Norbert, Aileen Hoehne, Frank Osterkamp, et al.. (2024). Preclinical Characterization of DPI-4452: A⁶⁸Ga/¹⁷⁷Lu Theranostic Ligand for Carbonic Anhydrase IX. Journal of Nuclear Medicine. 65(5). 761–767. 16 indexed citations

Hoehne, Aileen, et al.. (2023). 3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177. iScience. 26(12). 108541–108541. 11 indexed citations

Zboralski, Dirk, Frank Osterkamp, Aileen Hoehne, et al.. (2023). Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2621–2635. 27 indexed citations

Hoehne, Aileen, et al.. (2023). Modelling ligand depletion for simultaneous affinity and binding site quantification on cells and tissue. Scientific Reports. 13(1). 10031–10031. 2 indexed citations

Zboralski, Dirk, Aileen Hoehne, Matthias Paschke, et al.. (2022). Abstract 3317: Comparative biodistribution and radiotherapeutic efficacy of the fibroblast activation protein (FAP)-targeting agents FAP-2286 and FAPI-46. Cancer Research. 82(12_Supplement). 3317–3317. 4 indexed citations

Baum, Richard P., Christiane Schuchardt, Aviral Singh, et al.. (2021). Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results. Journal of Nuclear Medicine. 63(3). 415–423. 210 indexed citations breakdown →

Zboralski, Dirk, Frank Osterkamp, Andrew D. Simmons, et al.. (2020). 571P Preclinical evaluation of FAP-2286, a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP). Annals of Oncology. 31. S488–S488. 14 indexed citations

Baum, Richard P., Maythinee Chantadisai, Christiane Smerling, et al.. (2020). Peptide-Targeted Radionuclide Therapy (PTRT) using Lu-177 FAP-2286 in Diverse Adenocarcinomas: Feasibility, Biodistribution and Preliminary Dosimetry in a First-in-human study. 61. 633–633. 4 indexed citations

Hoehne, Aileen, Michelle L. James, Israt S. Alam, et al.. (2018). [18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis. Journal of Neuroinflammation. 15(1). 55–55. 22 indexed citations

10.

James, Michelle L., Aileen Hoehne, Aaron T. Mayer, et al.. (2017). Imaging B Cells in a Mouse Model of Multiple Sclerosis Using ⁶⁴Cu-Rituximab PET. Journal of Nuclear Medicine. 58(11). 1845–1851. 24 indexed citations

11.

James, Michelle L., Nadia P. Belichenko, Adam J. Shuhendler, et al.. (2017). [¹⁸F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease. Theranostics. 7(6). 1422–1436. 53 indexed citations

12.

Mittra, Erik, Norman Koglin, Camila Mosci, et al.. (2016). Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies. PLoS ONE. 11(2). e0148628–e0148628. 44 indexed citations

13.

Khalighi, Mehdi, Audrey P. Fan, Gaspar Delso, et al.. (2016). Image-based arterial input function estimation for cerebral blood flow measurement on a PET/MR scanner. 57. 1627–1627. 3 indexed citations

14.

Hoehne, Aileen. (2016). A novel strategy for imaging multiple sclerosis with positron emission tomography. 57. 112–112. 1 indexed citations

15.

Witney, Timothy H., Aileen Hoehne, Robert E. Reeves, et al.. (2015). A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment. Clinical Cancer Research. 21(17). 3896–3905. 52 indexed citations

16.

Witney, Timothy H., Michelle L. James, Bin Shen, et al.. (2015). PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2. Science Translational Medicine. 7(310). 310ra169–310ra169. 57 indexed citations

17.

Ding, Zhaoqing, Vidhu Mathur, Peggy P. Ho, et al.. (2014). Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. The Journal of Experimental Medicine. 211(2). 189–198. 52 indexed citations

18.

Gowrishankar, Gayatri, Mohammad Namavari, Aileen Hoehne, et al.. (2014). Investigation of 6-[18F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection. PLoS ONE. 9(9). e107951–e107951. 77 indexed citations

19.

Namavari, Mohammad, et al.. (2014). Synthesis of [18F]-labelled Maltose Derivatives as PET Tracers for Imaging Bacterial Infection. Molecular Imaging and Biology. 17(2). 168–176. 29 indexed citations

20.

Hoehne, Aileen, Deepak Behera, William H. Parsons, et al.. (2013). A ¹⁸F-Labeled Saxitoxin Derivative for in Vivo PET-MR Imaging of Voltage-Gated Sodium Channel Expression Following Nerve Injury. Journal of the American Chemical Society. 135(48). 18012–18015. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact